Loading insider details...
Latest Form 4 (Nov 4, 2026): Exercise/Conversion of 43,169 REPL shares, $75.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Replimune Group, Inc. (REPL) | Exercise/Conversion | 43,169 | $75.5K |
| Jun 29, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 40,000 | n/a |
| Apr 8, 2026 | Replimune Group, Inc. (REPL) | Grant/Award | 44,500 | n/a |
| Dec 11, 2025 | Replimune Group, Inc. (REPL) | Exercise/Conversion | 3,169 | $5.5K |
| Jun 12, 2025 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 30,550 | n/a |
| Apr 4, 2025 | Replimune Group, Inc. (REPL) | Grant/Award | 32,000 | n/a |
| Jun 6, 2024 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 30,550 | n/a |
| Jun 6, 2024 | CARGO Therapeutics, Inc. (CRGX) | Grant/Award | 11,871 | n/a |
| Apr 17, 2024 | CARGO Therapeutics, Inc. (CRGX) | Grant/Award | 49,265 | n/a |
| Apr 4, 2024 | Replimune Group, Inc. (REPL) | Grant/Award | 32,000 | n/a |